| |
|
|
|
|
|
|
|||
|
K Kitano, CI Rivas, GC Baldwin, JC Vera and DW Golde
Second Department of Internal Medicine, Shinshu University School of
Medicine, Nagano-Ken, Japan.
Tumor necrosis factor (TNF) may play a central role in proviral activation
and release from latency in cells infected with the human immunodeficiency
virus (HIV). We studied viral production and its relation to TNF in a HL-60
cell line (J22-HL-60) infected with a monocytotropic strain of HIV-1JR-FL.
Viral production was stimulated to similar levels by TNF,
12-O-tetradecanoyl-phorbol-13-acetate (TPA), and 1,25-dihydroxyvitamin D3
(1,25[OH]2D3). Production of the virus was not suppressed by
3'-azido-3'-deoxythymidine (AZT), indicating that viral production was not
caused by superinfection. Low concentrations of TNF (0.1 ng/mL) induced
viral production with a short lag period of 8 hours, and this proviral
activation was specifically suppressed by anti- TNF antibodies. However,
induction of virus production by 1,25(OH)2D3 showed an extended lag period
of 2 to 3 days. The effect of 1,25(OH)2D3 on virus production was also
blocked by anti-TNF antibodies, which suggests the direct participation of
TNF in this process. TNF accumulated in the culture supernatant of cells
stimulated with 1,25(OH)2D3 with a kinetics consistent with its involvement
in the action of 1,25(OH)2D3 on viral production. The J22-HL-60 cell line
produced low levels of virus when cultured in the absence of an external
stimulus; however, this basal viral production was suppressed greater than
80% in the presence of anti-TNF antibodies. Corresponding low levels of TNF
were detected in the culture supernatants. Viral production decreased
slowly with increasing passage of the cells, and no virus was detected in
the supernatants of cells maintained in culture for several months.
Concomitantly, TNF was no longer detected in the supernatant of these
cells, which suggests that endogenous autocrine production of TNF drives
viral production in the unstimulated cells. However, viral production was
stimulated in these cells by low concentrations (0.1 ng/mL) of added TNF.
These results argue for a central role for TNF in HIV proviral activation
in chronically infected myeloid cells.
This article has been cited by other articles:
| ||||||||||
| Copyright © 1993 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||